Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC365

Bimekisúmab

  • Status:
    Veitt
  • Application date:
    20.12.2021
  • Application published:
    15.1.2022
  • Grant published:
    15.2.2024
  • Max expiry date:
    22.8.2036
  • Medicine name:
    Bimzelx
  • Medicine for children:
    No

Timeline

Today
20.12.2021Application
15.1.2022Publication
15.2.2024Registration
22.8.2036Expires

Marketing license

  • IS authorization number:
    EU/1/21/1575/001-004; EU/1/21/1575/005-008
  • Date:
    1.9.2021
  • Foreign authorization number:
    EU/1/21/1575
  • Date:
    20.8.2021

Owner

  • Name:
    UCB Biopharma SRL
  • Address:
    Allée de la Recherche 60, Brussels BE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 19.01.2024

Upload documents